某三甲医院2014～2016年辅助用药使用分析

Utilization Analysis of Adjuvant Drugs in a Three-A Hospital during 2014 and 2016

目的:分析某三甲医院辅助用药使用情况,为该类药品合理使用提供参考。方法:分类统计该院2014~2016年辅助用药的销售金额、使用数量、销售金额排名前10位的辅助用药单品种用药频度(DDDs)、限定日费用(DDC)等数据。结果:该院2014~2016年辅助用药销售金额逐年上升,构成比均在30%以上。从类别看辅助用药销售金额排名前3位的是中药注射剂、神经营养类、肠内肠外营养类。DDDs位居前列的品种是单唾液酸神经四己酸神经节苷脂注射液、前列地尔注射液、注射用复合辅酶。结论:该院辅助用药品种多,消耗金额大,用药频次多,医院应加强管理,促进辅助用药的合理使用。

Objective ： To analyze the utilization of adjuvant drugs in a three-A hospital to provide reference for rational drug use in clinic. Methods： The utilization of top 10 adjuvant drugs in the list of consumption sum in the hospital was analyzed statistically in respects of total consumption and constituent ratio, the consumption sum of single type, DDDs and DDC, etc. Results： The total consumption increased year by year from 2014 to 2016, and the constituent ratio was over 30%. The top 3 adjuvant drugs in the list of consumption sum were traditional Chinese medicine injection, neurotrophic drugs and enteral nutrition （EN） and parenteral nutrition （PN） preparations. Monosialotetrahexosylganglioside sodium injection, alprostadil injection and coenzyme complex for injection were with the highest DDDs. Conclusion： The adjuvant drugs used in the hospital are with too many variety, too high consumption sum and too frequent administration. The hospital authority should take comprehensive measures to promote the rational use of adjuvant drugs.